A histone methyltransferase inhibitor can reverse epigenetically acquired drug resistance in the malaria parasite Plasmodium falciparum External Web Site Icon Chan A, et al. bioRxiv, Sep 19, 2019.

Specific PHGKB|<bean:write name="specificPHGKBForm" property="topic" />|PHGKB

Infectious Diseases

- Infectious Diseases PHGKB -

What's New

Last Posted: Sep 26, 2019

---

• A histone methyltransferase inhibitor can reverse epigenetically acquired drug resistance in the malaria parasite Plasmodium falciparum 
  Chan A, et al. bioRxiv, Sep 19, 2019.
• A qPCR assay for Bordetella pertussis cells that enumerates both live and dead bacteria. 
  Ramkissoon S, et al. bioRxiv, Sep 25, 2019.
• A unified sequence catalogue of over 280,000 genomes obtained from the human gut microbiome 
  Almeida A, et al. bioRxiv, Sep 19, 2019.
• Comparative genomics for the elucidation of multidrug resistance (MDR) in Candida lusitaniae 
  Kannan A, et al. bioRxiv, Sep 24, 2019.
• Evidence that vertical transmission of the vaginal microbiota can persist into adolescence 
  Bassis CM, et al. bioRxiv, Sep 16, 2019.
• Formula alters preterm infant gut microbiota and increases its antibiotic resistance load 
  Parnanen K, et al. bioRxiv, Sep 25, 2019.
• Genomes of intracellular Leishmania parasites directly sequenced from patients 
  Domagalska MA, et al. bioRxiv, Sep 26, 2019.
• Improving the usability and comprehensiveness of microbial databases 
  Loeffler C, et al. bioRxiv, Sep 26, 2019.
• Investigating Transfusion-Related Sepsis using Culture-Independent Metagenomic Sequencing 
  Crawford E, et al. bioRxiv, Sep 16, 2019.
• Microbiomes as sources of emergent host phenotypes 
  Lynch JB, Hsiao EY. Science, Sep 27, 2019.